Sensorion Aktie
| 9,61EUR | 0,05EUR | 0,52% |
WKN DE: A41Z9F / ISIN: FR001401A9Z0
Personal
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 39 | 46 | 57 | 63 | 63 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
Bilanz (in Mio. EUR) - Aktiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 57 | 36 | 43 | 86 | 55 |
| Summe Anlagevermögen | 2 | 3 | 3 | 4 | 3 |
| Summe Aktiva | 59 | 39 | 46 | 89 | 58 |
Bilanz (in Mio. EUR) - Passiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 15 | 17 | 13 | 17 | 13 |
| Summe Eigenkapital | 44 | 22 | 33 | 72 | 44 |
| Summe Passiva | 59 | 39 | 46 | 89 | 58 |
Adresse
| 375, rue du Professeur Joseph Blayac, 34080 Montpellier | |
| Telefon | +33 (4) 67-20-77-30 |
| Fax | +33 (4) 99-54-58-84 |
| Internet | http://www.sensorion.com |
Management
|
Amit Dilip Munshi
Chairman |
|
Aniz Girach
Independent Director |
|
Bernd Schmidt
Chief Technical Officer |
|
Cédric Moreau
Independent Director |
|
Eric Forquenot de la Fortelle
Independent Director |
|
Federico Mingozzi
Non-Executive Director |
|
Florian Nicolas Christian Reinaud
Director |
|
Frédéric Chéreau
Chief Executive Officer |
|
Géraldine Honnet
Chief Medical Officer |
|
Julien Miara
Independent Director |
|
Khalil Barrage
Independent Director |
|
Laurene Danon
Chief Financial Officer |
|
Natalie Berner
Director |
|
Nicolas Bogler
Head-Investor Relations & Communications |
|
Valerie Salentey
Director-Regulatory Affairs & Quality Assurance |